1315 Capital II L.P. 13D and 13G filings for Interpace Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-16 4:35 pm Purchase |
2024-10-11 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 9,405,940 68.000% |
6,239,274 (+197.03%) |
Filing |
| 2021-11-12 5:21 pm Unchanged |
2021-11-01 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 3,166,666 26.400% |
0 (Unchanged) |
Filing |
| 2021-05-19 5:39 pm Unchanged |
2021-05-10 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 3,166,666 26.500% |
0 (Unchanged) |
Filing |
| 2021-01-21 4:49 pm Unchanged |
2021-01-07 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 3,166,666 26.600% |
0 (Unchanged) |
Filing |
| 2020-04-30 08:15 am Unchanged |
2020-04-02 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 3,166,666 26.700% |
0 (Unchanged) |
Filing |